Genmab — April 2017
-
Super nyhed med JNJ-63709178. Læg mærke til, a tde har udvidet de mevirkende klinikker med flere af de absolut førende. For eksempel Memorial Sloan og M.D.Anderson og adskillige universitetsklinikker af de kendte. Ser ud til, at de har brugt pausen endog meget konstruktivt til at etablere ny start.
-
By the way, i checked with Janssen on twitter to be sure, as there was no other source: "@JanssenGlobal It appears from http://clinicaltrials.gov study NCT02715011 is not 'suspended' anymore, could you confirm that? JNJ-63709178 " Answer: "Thank you for your ques
tion. Yes, the status has changed." -
When a proposed study is placed on clinical hold, subjects may not be given the investigational drug. When an ongoing study is placed on clinical hold, no new subjects may be recruited to the study and given the investigational drug; patients already in the study are expected to be taken off therapy involving the investigational drug unless treatment continuation is specifically permitted by FDA in the interest of patient safety.
-
Nu har selv "skarpe Langer" indset det, "Genmab har fået for mange tæsk efter en nyhed uden nævneværdig betydning i det store billede" http://www.business.dk/investor/vigtige-aktieindikatorer-viser-ny-robusthed-er-det-oplaegget-til-endnu-et?referrer=RSS
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind